Facebook Pixel Code

Biotech sector seeks sops to meet revenue target of $100 bn by 2025

The Association of Biotechnology Led Enterprises, the apex body of the biotech sector in India, has sought an increase in weight tax deduction and extending its applicability to activities such as clinical trials and setting up venture capital funds.

The Association of Biotechnology Led Enterprises (ABLE), the apex body of the biotech sector in India, has sought an increase in weight tax deduction and extending its applicability to activities such as clinical trials and setting up venture capital funds.

In its pre-Budget memorandum to the Union finance ministry, the association also sought an increase in grants for advanced skills development programmes, exemption from excise/custom duties on life-saving medicines as well as on their raw materials and also on capital goods and consumables, CROs, diagnostic kits apart from providing tax holidays and soft loans, price fixing for ethanol and allocation of corpus fund which would help the industry’s growth.

?The recommendations, if implemented, will enable the Indian biotech sector to achieve the target growth rate of 25-30% and generate revenues of $100 billion by 2025, while empowering the domestic industry to become global power,” said PM Murali, president, ABLE.

Get live Share Market updates, Stock Market Quotes, and the latest India News and business news on Financial Express. Download the Financial Express App for the latest finance news.

First published on: 02-01-2013 at 00:15 IST
Market Data
Market Data
Today’s Most Popular Stories ×